How Often Should Cancer Screening Be Repeated? What Experts Generally Agree On

Regular cancer screening is important because it allows cancer to be detected at an early stage. Catching cancer early typically means that there are more options for treatment, and treatment may be more effective. [1] Finding and treating cancer and precancerous changes at an earlier and more treatable stage can improve survival rates and even decrease the cost of treating cancer.

By empowering you to take charge of your health, cancer screening and other preventive healthcare screenings help you make informed decisions to keep you safe and healthy.

Many organizations make recommendations regarding routine cancer screening. In the United States, one of the primary organizations that sets these guidelines is the United States Preventive Services Task Force (USPSTF).

The USPSTF reviews evidence regarding the benefits and risks of various preventive services, identifies gaps in research, and makes recommendations regarding the recommended types and frequency of preventive screenings, including cancer screening. [2]

Other organizations also make recommendations on the frequency of preventive testing, including cancer screening. Often, these organizations agree with the USPSTF recommendations, but sometimes they disagree. [3]

When the experts disagree on which tests or frequencies are best, your healthcare provider is your best resource to help you with a preventive health screening plan to meet your unique needs.

Some cancers have one preferred screening test, while others have multiple screening tests available. Most screening guidelines are for people who are at average risk of developing that type of cancer. People with an increased risk for cancer due to their family history, genetic markers, or lifestyle factors may need to be on a different schedule or have different tests.

Cervical Cancer

• Before age 21 – No routine screening
• Age 21-29 – Pap smear every 3 years
• Age 30-65 – Pap smear every 3 years, high-risk HPV testing every 5 years, PAP smear plus HPV testing every 5 years
• After age 65 – No additional screening if 3 negative PAP smears or 2 negative HPV tests or 2 negative PAP smears plus HPV tests in the previous 10 years

Breast Cancer

The American Cancer Society differs slightly from the USPSTF recommendation and bases its recommendations on a patient's age. [6]

• Women age 40-44 – optional mammogram every year
• Women age 45-54 – mammogram every year
• Women 55 and over – mammogram every one to two years as long as the person has a life expectancy of at least 10 years

Colon Cancer Screening

Colon cancer screening options vary based on risk, but there are several choices. The USPSTF currently recommends colorectal cancer screening beginning at age 45 for people with an average risk of colon cancer. Screening should continue until at least age 75, at intervals determined by the specific screening test used and the individual’s risk factors. People aged 76-85 may continue screening depending on their overall health status and prior screening history. [7]

Options for colon cancer screening include [8]:

• Fecal Occult Blood Testing (FOBT): yearly
• Fecal Immunotesting (FIT): yearly
• Occult blood and DNA testing: every three years
• Sigmoidoscopy: every five years
• Virtual colonoscopy (CT colonography): every five years
• Colonoscopy: every 10 years if negative in average-risk individuals; people with polyps or with a family history may need more frequent screening

Lung Cancer Screening

Prostate Cancer Screening

• Men aged 50 or older who are at average risk for prostate cancer
• Men aged 45 who are at higher risk for prostate cancer, including men of African American descent, and men with a first-degree relative with prostate cancer diagnosed before age 65
• Men aged 40 who are at very high risk, such as those with multiple first-degree relatives with prostate cancer, especially if the relatives were diagnosed before age 65

Most of the recommendations for cancer screening frequency are based on the assumption that the person is of average risk for that type of cancer. Many factors can contribute to an increased risk of developing cancer. Some of these include [12]:

• Genetic mutations
• Personal history of cancer or precancer
• Heavy alcohol use
• Occupational exposures
• Chronic inflammatory diseases
• Some medications
• Smoking
• Having obesity
• Family history of cancer

Delayed diagnosis can lead to the need for more aggressive treatment and side effects of treatment. It can also affect the survival rate. If you miss a screening, reschedule the test as soon as you are able. Staying current with your preventive health screenings, including cancer screening, can help you stay healthy over time.

Want to learn more about cancer screening and early detection? Everlywell has your back. We have a range of tests available to help detect cancer in its earliest stages. The Galleri® Multi-Cancer Early Detection Test uses cell-free DNA to detect more than 50 types of cancer.

At Everlywell, we also offer a range of at-home tests to help inform your healthcare journey. Our virtual care visits give you access to a certified healthcare provider who can answer questions and make recommendations for cancer screening unique to your health profile and risk factors. It’s healthcare on your schedule from the privacy of your home.

References

1. Wilkinson AN. Evidence-based truths about the benefit of cancer screening. Canadian Family Physician. 2024;70(5):296.1-296. doi:10.46747/cfp.7005296. https://pmc.ncbi.nlm.nih.gov/articles/PMC11280647/
2. About the USPSTF | United States Preventive Services Taskforce. Accessed February 18, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf
3. Ebell MH, Lin KW. Evidence considerations for recent USPSTF recommendations. AAFP. Published February 15, 2025. https://www.aafp.org/pubs/afp/issues/2025/0200/editorial-uspstf-recommendations.html
4. Updated Cervical cancer screening guidelines. ACOG. Reaffirmed April, 2024. Accessed February 18, 2026. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines
5. Breast cancer: screening. Published April 30, 2024. Accessed February 18, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
6. ACS Breast Cancer Screening Guidelines. American Cancer Society. Accessed February 18, 2026. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-%20cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
7. Saslow D, Boetes C, Burke W, et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography. CA: A Cancer Journal for Clinicians. 2007;57(2):75-89. doi:10.3322/canjclin.57.2.75. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/canjclin.57.2.75
8. Colorectal cancer: screening. Published May 18, 2021. Accessed February 18, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
9. Colorectal Cancer guideline | How often to have screening tests. American Cancer Society. Accessed February 18, 2026. https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html
10. Lung cancer: screening. Published March 9, 2021. Accessed February 18, 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
11. American Cancer Society Recommendations for Prostate Cancer Early Detection. American Cancer Society. Accessed February 18, 2026. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html
12. Patel AV, Deubler E, Teras LR, et al. Key risk factors for the relative and absolute 5‐year risk of cancer to enhance cancer screening and prevention. Cancer. 2022;128(19):3502-3515. doi:10.1002/cncr.34396. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34396